Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Research, Drug Development & Manufacturing
Clinical Trial InfrastructureSite Networks & SMOs
Research, Drug Development & Manufacturing

New Zealand Clinical Research (NZCR)

Physician-led New Zealand clinical research organization with early-phase specialization and multi-site operations; identified in partner disclosures as experienced in psychedelic studies.

Clinical Trial Infrastructure Snapshot

Site Networks & SMOs

Service Model

Site Network / SMO

Coverage

Coverage not set

Psychedelic Experience

Claimed Psychedelic Trial Experience

Last Verified

Apr 8, 2026

Lifecycle Coverage

Study Startup & Site ActivationRecruitment & RetentionTrial Operations & MonitoringData Management & Biostatistics

Phase Coverage

Phase IPhase IIPhase III

Capabilities

Site Network AccessPatient Recruitment Media

Verification

Verified

Experience Notes

Novotech’s public announcement describes NZCR as a leading early-phase center with a strong track record in psychedelic studies and prior collaboration on multiple psychedelic trials.

Primary Service Link

Service Notes

NZCR highlights physician-led early-phase execution, multiple New Zealand units, and regulatory expertise supporting both healthy volunteer and patient population studies.

Source Evidence

NZCR — About NZCR

https://www.nzcr.co.nz/about-us/about-nzcr/

NZCR — Our Expertise

https://www.nzcr.co.nz/sponsors/our-expertise/

Novotech — MOU with NZCR (Psychedelics)

https://novotech-cro.com/news/novotech-announces-mou-experienced-psychedelics-research-center-4th-annual-psychedelic

Quick Facts

Website
Visit